NASDAQ: ESPR Long Term Investor Notice: Investigation of Potential Wrongdoing at Esperion Therapeutics, Inc.
An investigation was announced for investors in shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) over possible breaches of fiduciary duties by certain directors and officers of Esperion Therapeutics, Inc..
View full press release